Back
Intra-Cellular Therapies Stock Price Chart
$1,300 into $45,000 in just 4 MONTHS?!
See here to see the full details.
Sell
50
ITCI
Intra-Cellular Therapies
Last Price:
80.46
Seasonality Move:
-0.5%
7 Day Trial
ALL ACCESS PASS
$
7
Wall Street's Worst Nightmare: Small Town Trader's AI Edge
See the AI advantage for everyday Americans.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ITCI is experiencing slight selling pressure.
Intra-Cellular Therapies Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 77.45 | Buy |
| 20-day SMA: | 74.99 | Buy |
| 50-day SMA: | 71.3 | Buy |
| 200-day SMA: | 66.54 | Buy |
| 8-day EMA: | 78.19 | Buy |
| 20-day EMA: | 75.94 | Buy |
| 50-day EMA: | 72.98 | Buy |
| 200-day EMA: | 67.47 | Buy |
Intra-Cellular Therapies Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.24 | Buy |
| Relative Strength Index (14 RSI): | 65.86 | Buy |
| Chaikin Money Flow: | -135248 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
Intra-Cellular Therapies Technical Analysis
| Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 19 | Jul 22 | Jul 23 | Jul 24 | Jul 25 | Jul 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Intra-Cellular Therapies Stock
Is Intra-Cellular Therapies Stock a Buy?
- Intra-Cellular Therapies share price is 80.39 while ITCI 8-day simple moving average is 77.45, which is a Buy signal.
- The stock price of ITCI is 80.39 while Intra-Cellular Therapies 20-day SMA is 74.99, which makes it a Buy.
- Intra-Cellular Therapies 50-day simple moving average is 71.30 while ITCI share price is 80.39, making it a Buy technically.
- ITCI stock price is 80.39 and Intra-Cellular Therapies 200-day simple moving average is 66.54, creating a Buy signal.
ITCI Technical Analysis vs Fundamental Analysis
Sell
50
Intra-Cellular Therapies (ITCI)
is a Sell
Is Intra-Cellular Therapies a Buy or a Sell?
-
Intra-Cellular Therapies stock is rated a Sell
The current Intra-Cellular Therapies [ITCI] share price is $80.39. The Score for ITCI is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
Intra-Cellular Therapies Stock Info
Market Cap:
8.49B
Price in USD:
80.39
Share Volume:
534.75K
Intra-Cellular Therapies 52-Week Range
52-Week High:
84.89
52-Week Low:
45.50
Sell
50
Intra-Cellular Therapies (ITCI)
is a Sell
Intra-Cellular Therapies Share Price Forecast
-
What is the Intra-Cellular Therapies stock price today?
The Intra-Cellular Therapies stock price is 80.39 USD today. -
Will ITCI stock go up or go down?
Intra-Cellular Therapies> share price is forecast to RISE/FALL based on technical indicators -
Is Intra-Cellular Therapies overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Intra-Cellular Therapies is overvalued.
Is Intra-Cellular Therapies Stock a Buy?
- Intra-Cellular Therapies share price is 80.39 while ITCI 8-day exponential moving average is 78.19, which is a Buy signal.
- The stock price of ITCI is 80.39 while Intra-Cellular Therapies 20-day EMA is 75.94, which makes it a Buy.
- Intra-Cellular Therapies 50-day exponential moving average is 72.98 while ITCI share price is 80.39, making it a Buy technically.
- ITCI stock price is 80.39 and Intra-Cellular Therapies 200-day simple moving average is 67.47, creating a Buy signal.
Fundamental Analysis of Intra-Cellular Therapies
Is Intra-Cellular Therapies a good investment?
- Analysts estimate an earnings increase this quarter of $0.44 per share, an increase next quarter of $0.09 per share, an increase this year of $1.09 per share, and an increase next year of $1.57 per share.
Technical Analysis of Intra-Cellular Therapies
Should I short Intra-Cellular Therapies stock?
- ITCI Moving Average Covergence Divergence (MACD) indicator is 2.24, suggesting Intra-Cellular Therapies is a Buy
- Intra-Cellular Therapies Relative Strength Index (RSI) is 65.86, which suggest Intra-Cellular Therapies is overbought
- The Bollinger Bands (25) for Intra-Cellular Therapies is ( - ), which suggest Intra-Cellular Therapies is a Buy
- The Bollinger Bands (100) for Intra-Cellular Therapies is ( - ), which suggest Intra-Cellular Therapies is a Buy
* Intra-Cellular Therapies stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.